Abstract:
In the recent years, Bioresorbable Vascular Scaffolds (BVS) for the treatment of atherosclerosis have been introduced. InSilc is a cloud based in silico clinical trial (I...Show MoreMetadata
Abstract:
In the recent years, Bioresorbable Vascular Scaffolds (BVS) for the treatment of atherosclerosis have been introduced. InSilc is a cloud based in silico clinical trial (ISCT) platform for drug-eluting BVS. The platform integrates multidisciplinary and multiscale models predicting the BVS performance. In this study, we present a use case scenario and demonstrate the functioning of the individual modules and of the whole pipeline and the ability to predict BVS short, medium, long-term outcomes.
Published in: 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC)
Date of Conference: 20-24 July 2020
Date Added to IEEE Xplore: 27 August 2020
ISBN Information:
ISSN Information:
PubMed ID: 33018557